Clinical trial
Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
NCT00581607 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
- Lead sponsor
- University of Cincinnati
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 30, 2008
- Completion date
- December 31, 2012
- Enrollment
- 43 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.